Pfizer erwägt Verkauf seiner Krankenhausmedikamente-Sparte Von Investing.com

Pfizer Inc. (NYSE:) has completed the sale of Krankenhausmedikamente-Sparte, incorporated as Pfizer Hospital. This separation is the part of the ternehmensstrategy, if there are no core geschäften, the drucks will focus on an active Investor Starboard Value. Pfizer Hospital, which was admitted to the hospital after the 17 million US dollars in the year 2015, has specialized antibiotics and other sterile invisible agents for the Krankenhaus gebrauch.

The pharmaceutical industry that Goldman Sachs founded offers exciting avenues of interest for its sons, private equity firms and other pharmaceutical companies. Industry experts estimate the value of the expenditure at more than a million dollars, with some profits for sentences, shares, depreciation and amortization (EBITDA) of nahezu 500 million dollars.

Allerdings are Insider, the knowledge gained from the Anonymous Delay is woolly, and the Verkauf-keinesweg is beschlossene Sache ist. Pfizer wants them to remain separated, this Tochtergesellschaft will be managed.

In the vergangen monates that Pfizer has made non-essential debt and investments and other companies have rejected, debts have been created that have fallen by $61.5 billion in dollars at the end of 2023. A curious writer in this direction war was a $3.26 million advance in the British economy in October.

The company led by CEO Albert Bourla was criticized for Starboard. The active investor is attracted by the large investments, while he will make profitable new investments – returning from those investments, nor from the internal investments and investments. One of the great wars that destroys US$43 billion in lending to credit repairers in one year.

Thanks to this strategic strategy, the Pfizer stock has not made any money in those years and has delivered a return of 7%, while the S&P 500 has quickly risen 26%. In one of the financial conference calls after the profit calculation, Pfizers financing was financed by Dave Denton, who saved the debtor a value of US$4.4 billion in those years a few years ago. If you want to take the next step in the development of the core innovation, the Bilanz is still as strong.

Reuters hat zu diesem Artikel beigetragen.

This description can be performed by the intelligent intelligence. Weitere Informationen entnehmen Sie bitte unseren Nutzungsbedingungen.